ScholarLens Back to search
2007•PubMedRequires access

[A case of lung adenocarcinoma keeping complete remission by treatment with gefitinib].

Koichi Imai, Jun-ichi Ashitani, Shigehisa Yanagi, Tsuyoshi Kodama, Yuka Kyoraku, Arisa Sano, Nobuhiro Matsumoto, Masamitsu Nakazato

Open publisher page 1 citations

Abstract

A 74-year-old smoking man was admitted because of lung cancer with metastatic brain tumor. Examinations for lung cancer and brain tumor showed adenocarcinoma (clinical stage IV). Four courses of chemotherapy were not effective. Administration of gefitinib started from June 2003, but was halted after only two months because of skin rash. Lung tumor disappeared on chest computerized tomography in January 2004 and no recurrence has been detected as of March 2006. This is a rare male super-responder to gefitinib.

About this research paper

What this paper is about

A 74-year-old smoking man was admitted because of lung cancer with metastatic brain tumor. Examinations for lung cancer and brain tumor showed adenocarcinoma (clinical stage IV). Four courses of chemotherapy were not effective. Administration of gefitinib started from June 2003, but was halted after only two months because of skin rash. Lung tumor disappeared on chest computerized tomography in January 2004 and no recurrence has been detected as of March 2006. This is a rare male super-responder to gefitinib.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A 74-year-old smoking man was admitted because of lung cancer with metastatic brain tumor. Examinations for lung cancer and brain tumor showed adenocarcinoma (clinical stage IV). Four courses of chemotherapy were not effective. Administration of gefitinib started from June 2003, but was halted after only two months because of skin rash. Lung tumor disappeared on chest computerized tomography in January 2004 and no recurrence has been detected as of March 2006. This is a rare male super-responder to gefitinib.

Key concepts: Gefitinib, Medicine, Adenocarcinoma, Rash, Lung cancer, Adenocarcinoma of the lung, Internal medicine, Lung

Back to paper searchBrowse research topicsOriginal source
[A case of lung adenocarcinoma keeping complete remission by treatment with gefitinib]. — Research Paper | ScholarLens